Pancreatic Cancer Research

ResearcherHong Kong Polytechnic UniversityActive in the last 2 years

Huan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2289-7707; OpenAlex author ID A5100356951. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2014: 2 papers · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 4 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 13

  1. Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory facto… Co-author DOI 10.1038/s41392-025-02562-8↗
  2. Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis. Co-author DOI 10.3389/fimmu.2025.1555036↗
  3. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer. First author DOI 10.1111/imm.13496↗
  4. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. Co-author DOI 10.1186/s12964-021-00806-y↗
  5. Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. Co-author DOI 10.1186/s12964-021-00808-w↗
  6. CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression. Co-author DOI 10.7150/ijbs.68995↗
  7. CD248(TEM1/CD164L1/Endosialin): A new molecular target for anti-angiogenic therapy in Pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-217476/v1↗
  8. Heterogeneous Pancreatic Stellate Cells Are Powerful Contributors to the Malignant Progression of Pancreatic Cancer. First author DOI 10.3389/fcell.2021.783617↗
  9. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis. Co-author DOI 10.1186/s12935-020-01558-4↗
  10. Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells. Co-author DOI 10.1007/s12032-015-0513-2↗
  11. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-14-2040↗
  12. Prostate-specific membrane antigen as a marker of pancreatic cancer cells. First author DOI 10.1007/s12032-014-0857-z↗
  13. Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2014.08.001↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daorong Wang · 5 shared papers, 2021–2022 · strength 0.85
  2. Dong Tang · 5 shared papers, 2021–2022 · strength 0.85
  3. Ruining Gong · 2 shared papers, 2025–2026 · strength 0.49
  4. Zhilin Zhang · 2 shared papers, 2021–2022 · strength 0.36
  5. He Ren · 4 shared papers, 2014–2026 · strength 0.32
  6. Heshui Wu · 2 shared papers, 2020–2022 · strength 0.31
  7. Xin Jin · 2 shared papers, 2020–2022 · strength 0.31
  8. Qian Yu · 1 shared paper, 2025 · strength 0.30
  9. Zimin Liu · 1 shared paper, 2025 · strength 0.30
  10. David Kuang-Fu Chang · 1 shared paper, 2025 · strength 0.30
  11. Wenjie Zhang · 2 shared papers, 2021–2022 · strength 0.28
  12. Lin Shi · 1 shared paper, 2022 · strength 0.20
  13. Jihui Hao · 4 shared papers, 2014–2015 · strength 0.19
  14. Chao Gao · 1 shared paper, 2026 · strength 0.19
  15. Qian Yu · 1 shared paper, 2026 · strength 0.19
  16. Shanglong Liu · 1 shared paper, 2026 · strength 0.19
  17. Xiaoya Shi · 1 shared paper, 2026 · strength 0.19
  18. Qinghui Niu · 1 shared paper, 2026 · strength 0.19
  19. Ashok Kumar Saluja · 1 shared paper, 2026 · strength 0.19
  20. Jieer Ying · 1 shared paper, 2026 · strength 0.19
  21. Dianyun Ren · 1 shared paper, 2020 · strength 0.16
  22. Yingke Zhou · 1 shared paper, 2022 · strength 0.15
  23. Yan Sun · 1 shared paper, 2022 · strength 0.15
  24. Hongkun Cai · 1 shared paper, 2022 · strength 0.15
  25. Feng Guo · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.